Cargando…

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behavio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieniawska, Joanna, Lesiak, Aleksandra, Ciążyński, Karol, Narbutt, Joanna, Ciążyńska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835216/
https://www.ncbi.nlm.nih.gov/pubmed/35162757
http://dx.doi.org/10.3390/ijerph19031734
_version_ 1784649374839603200
author Sieniawska, Joanna
Lesiak, Aleksandra
Ciążyński, Karol
Narbutt, Joanna
Ciążyńska, Magdalena
author_facet Sieniawska, Joanna
Lesiak, Aleksandra
Ciążyński, Karol
Narbutt, Joanna
Ciążyńska, Magdalena
author_sort Sieniawska, Joanna
collection PubMed
description Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period.
format Online
Article
Text
id pubmed-8835216
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88352162022-02-12 Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients Sieniawska, Joanna Lesiak, Aleksandra Ciążyński, Karol Narbutt, Joanna Ciążyńska, Magdalena Int J Environ Res Public Health Article Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period. MDPI 2022-02-02 /pmc/articles/PMC8835216/ /pubmed/35162757 http://dx.doi.org/10.3390/ijerph19031734 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sieniawska, Joanna
Lesiak, Aleksandra
Ciążyński, Karol
Narbutt, Joanna
Ciążyńska, Magdalena
Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title_full Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title_fullStr Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title_full_unstemmed Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title_short Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
title_sort impact of the covid-19 pandemic on atopic dermatitis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835216/
https://www.ncbi.nlm.nih.gov/pubmed/35162757
http://dx.doi.org/10.3390/ijerph19031734
work_keys_str_mv AT sieniawskajoanna impactofthecovid19pandemiconatopicdermatitispatients
AT lesiakaleksandra impactofthecovid19pandemiconatopicdermatitispatients
AT ciazynskikarol impactofthecovid19pandemiconatopicdermatitispatients
AT narbuttjoanna impactofthecovid19pandemiconatopicdermatitispatients
AT ciazynskamagdalena impactofthecovid19pandemiconatopicdermatitispatients